Dr Miguel A Conde, MD in Livingston, NJ - Medicare Hematology/oncology

Dr Miguel A Conde, MD is a medicare enrolled "Internal Medicine - Hematology & Oncology" physician in Livingston, New Jersey. He went to Columbia University College Of Physicians And Surgeons and graduated in 1986 and has 38 years of diverse experience with area of expertise as Hematology/oncology. He is a member of the group practice Medical Oncology Associates At Saint Barnabas and his current practice location is 94 Old Short Hills Rd, Livingston, New Jersey. You can reach out to his office (for appointments etc.) via phone at (973) 322-5200.

Dr Miguel A Conde is licensed to practice in New Jersey (license number 25MA05924500) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1093795270.

Contact Information

	Dr Miguel A Conde, MD
	94 Old Short Hills Rd, Livingston, NJ 07039-5672
	(973) 322-5200
	Not Available

Physician's Profile

Full Name	Dr Miguel A Conde
Gender	Male
Speciality	Hematology/oncology
Experience	38 Years
Location	94 Old Short Hills Rd, Livingston, New Jersey
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Miguel A Conde attended and graduated from Columbia University College Of Physicians And Surgeons in 1986

NPI Data:

NPI Number: 1093795270
Provider Enumeration Date: 01/23/2006
Last Update Date: 06/07/2013

Medicare PECOS Information:

PECOS PAC ID: 0244260586
Enrollment ID: I20050817000089

Medical Identifiers

Medical identifiers for Dr Miguel A Conde such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1093795270	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207RH0003X	Internal Medicine - Hematology & Oncology	25MA05924500 (New Jersey)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Saint Barnabas Medical Center	Livingston, NJ	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Medical Oncology Associates At Saint Barnabas	0547220386	11

News Archive

Inhibitex reports Q2 2009 financials

Inhibitex, Inc. (Nasdaq: INHX), today announced its financial results for the second quarter ended June 30, 2009. The Company held cash, cash equivalents and short-term investments of $24.5 million at June 30, 2009, as compared to $33.1 million at December 31, 2008.

Update on FDA's review of BSD-2000 Hyperthermia System for patients with cervical carcinoma provided

BSD Medical Corporation (www.bsdmedical.com) today provided an update on the U.S. Food and Drug Administration's (FDA) review of the Company's Humanitarian Device Exemption (HDE) marketing submission for the Company's BSD-2000 Hyperthermia System.

Onyx announces results from regorafenib Phase 3 trial on GIST

Onyx Pharmaceuticals, Inc. today announced results from the Phase 3 trial GRID (GIST – Regorafenib in Progressive Disease) evaluating the investigational compound regorafenib (BAY 73-4506), a Bayer-owned compound, for the treatment of patients with metastatic and/or unresectable gastrointestinal stromal tumors (GIST) whose disease has progressed despite prior treatment with at least imatinib and sunitinib.

Suppressing brain immune cells might prevent or delay the onset of dementia

Messy tangles of a protein called tau can be found in the brains of people with Alzheimer's disease and some other neurodegenerative diseases. In Alzheimer's, the tangles coalesce just before tissue damage becomes visible in brain scans and people start to become forgetful and confused.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Miguel A Conde allows following entities to bill medicare on his behalf.

Entity Name	Medical Oncology Associates At Saint Barnabas
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1689622748 PECOS PAC ID: 0547220386 Enrollment ID: O20041015000127

News Archive

Inhibitex reports Q2 2009 financials

Update on FDA's review of BSD-2000 Hyperthermia System for patients with cervical carcinoma provided

Onyx announces results from regorafenib Phase 3 trial on GIST

Suppressing brain immune cells might prevent or delay the onset of dementia

Entity Name	Barnabas Health Medical Group Pc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1841557246 PECOS PAC ID: 9537316955 Enrollment ID: O20120820000951

Inhibitex reports Q2 2009 financials

Update on FDA's review of BSD-2000 Hyperthermia System for patients with cervical carcinoma provided

Onyx announces results from regorafenib Phase 3 trial on GIST

Suppressing brain immune cells might prevent or delay the onset of dementia

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Miguel A Conde is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Miguel A Conde, MD 94 Old Short Hills Rd, Livingston, NJ 07039-5672 Ph: (973) 322-5200	Dr Miguel A Conde, MD 94 Old Short Hills Rd, Livingston, NJ 07039-5672 Ph: (973) 322-5200

News Archive

Inhibitex reports Q2 2009 financials

Update on FDA's review of BSD-2000 Hyperthermia System for patients with cervical carcinoma provided

Onyx announces results from regorafenib Phase 3 trial on GIST

Suppressing brain immune cells might prevent or delay the onset of dementia

Internal Medicine Doctors in Livingston, NJ

Bilal Khan, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 94 Old Short Hills Rd, Livingston, NJ 07039 Phone: 646-591-5953
Dr. Bruce Joseph Haik, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 94 Old Short Hills Road Suite 2511, Livingston, NJ 07039 Phone: 973-731-9442 Fax: 973-731-2918
Parvathy Thiruwilwamala, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 94 Old Short Hills Rd, Livingston, NJ 07039 Phone: 973-322-5000
Dr. Michael Gutkin, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 349 E Northfield Rd, Suite 202, Livingston, NJ 07039 Phone: 973-597-1107 Fax: 973-597-1407
Dr. Eugene Ludwig Evans Jr., M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 2 W Northfield Rd, Suite 211, Livingston, NJ 07039 Phone: 973-758-0044 Fax: 973-758-0055
Dr. Stuart E Baskin, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 315 E Northfield Rd, Suite 1a, Livingston, NJ 07039 Phone: 973-994-2121 Fax: 973-535-8191
Jill Ritter, MD Hematology & Oncology Medicare: May Accept Medicare Assignments Practice Location: 200 S Orange Ave, Livingston, NJ 07039 Phone: 973-322-7400 Fax: 973-322-7420

Dr Miguel A Conde, MD - Medicare Hematology/oncology in Livingston, NJ

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

Inhibitex reports Q2 2009 financials

Update on FDA's review of BSD-2000 Hyperthermia System for patients with cervical carcinoma provided

Onyx announces results from regorafenib Phase 3 trial on GIST

Suppressing brain immune cells might prevent or delay the onset of dementia

Medicare Reassignments

Inhibitex reports Q2 2009 financials

Update on FDA's review of BSD-2000 Hyperthermia System for patients with cervical carcinoma provided

Onyx announces results from regorafenib Phase 3 trial on GIST

Suppressing brain immune cells might prevent or delay the onset of dementia

Inhibitex reports Q2 2009 financials

Update on FDA's review of BSD-2000 Hyperthermia System for patients with cervical carcinoma provided

Onyx announces results from regorafenib Phase 3 trial on GIST

Suppressing brain immune cells might prevent or delay the onset of dementia

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Inhibitex reports Q2 2009 financials

Update on FDA's review of BSD-2000 Hyperthermia System for patients with cervical carcinoma provided

Onyx announces results from regorafenib Phase 3 trial on GIST

Suppressing brain immune cells might prevent or delay the onset of dementia

Internal Medicine Doctors in Livingston, NJ